Rankings
▼
Calendar
MLTX Q4 2020 Earnings — MoonLake Immunotherapeutics Revenue & Financial Results | Market Cap Arena
MLTX
MoonLake Immunotherapeutics
$1B
Q4 2020 Earnings
Healthcare
Biotechnology
Income Statement
Revenue
$0
Gross Profit
$0
Operating Income
-$100,755
Net Income
-$85,838
EPS (Diluted)
$-0.01
← FY 2020
All Quarters
Q1 2021 →
